Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
45.25    2.75 (6.47%)
Bid:
44.50
Ask:
46.00
Spread: 1.50 (3.371%)
Market Cap: £86.82m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Trading Update

14 Dec 2015 07:00

RNS Number : 8858I
Iofina PLC
14 December 2015
 

 

14 December 2015

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Oklahoma Operations Update

Full year production up 75% year on year

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, notes the recent decline in the Company's share price and provides the following update on the Company's iodine production in the State of Oklahoma in order to reassure and update shareholders on the Company's current operations.

 

The Board confirms that, despite production levels being impacted by downtime due to its partners' work on the Salt Water Disposal ("SWD"), coupled with recent weather-related power outages, Iofina expects to meet its forecasts and produce between 276-286 metric tonnes ("MT") of crystalline iodine in H2 2015, resulting in full year production of 570 to 580 MT of crystalline iodine (2014: 328 MT), a like-for-like increase of 75%.

As reported on 23 November 2015, the Company informed the market of actions taken by the Oklahoma Corporation Commission ("OCC") with respect to curtailing some SWD Injection Wells in areas where larger magnitude seismic activity had recently occurred. Currently Iofina's two partners are disposing of in excess of 500,000 barrels of brine water per day ("bwpd") in the Mississippi Lime play. Iofina is currently processing near 100,000 bwpd. Thus, there is an abundant source of brine in the area of the Company's production. Although seismic activity continues in Oklahoma, resulting in the OCC issuing further restrictions for some SWDs located east of the Company's production area, the Board is pleased to report that this does not directly affect the SWDs at the sites of Iofina's IOsorb® plants. 

Iofina's partners continue to expand operations in the Company's production area with relative downtime at plants IO#4 and IO#6 recently due to brine diversion for fracturing operations. Since the initial OCC restrictions, the Company has seen a decrease in brine available at IO#3 and IO#5. Although this is anticipated to continue in the near term, brine availability is expected to be only marginally down year-on-year.

The Company confirms that its other sites currently remain unaffected, but continues to consult with its partners about the possible effects of OCC restrictions. The Company expects the current reduction in injection volumes, if sustained, would result in 2016 full year production from its current plants being flat to 10% down year-on-year. The Company will update the market as this matter becomes clearer.

For the long term, Iofina is working closely with its partners to investigate other means to access brine water at its plants, which would avoid the need for direct association with particular SWDs. The Company has successfully piloted an alternative brine supply mechanism during a recent workover of one of its partner's SWDs this summer. Additionally, continued efficiencies in Iofina's process and reduction in Company costs of extraction will further mitigate the potential reduction in brine supply.

 

 

Commenting, President and CEO Tom Becker stated:

"I wish to reassure all shareholders that the Company has done all it can to mitigate further impact resulting from the seismic activity reported last month. It is encouraging that, despite this activity, the Company will achieve this year's target production figure, which is itself up 75% year-on-year.

"While there is brine loss, our production levels are expected to be broadly flat in 2016. We continue to work closely with our partners, pending the outcome of discussions with the OCC to source alternative supplies. The Board acknowledges the disappointing decline in the share price but reaffirms that that the Company is operationally robust."

 

For further information, please contact:

 

Dr. Tom Becker, CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Christopher Raggett/Giles Rolls/Joanna Scott

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Rob Collins/Emily Morris

GMP Securities

Tel: +44(0)20 7647 2800

 

Media Contact:

Dominic Barretto/Harriet Jackson

Yellow Jersey PR Limited

Tel: +44 (0)7768 537 739

About Iofina:

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb® technology. Iofina has production operations in the United States, specifically in Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes. Iofina utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

www.iofina.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLDFDLVLIE
Date   Source Headline
14th May 20197:00 amRNSStatement regarding share price rise
1st May 20197:00 amRNSFinal Results
17th Apr 20197:00 amRNSQ1 2019 Market Update
1st Apr 20197:00 amRNSCompletion of Debt Restructuring
22nd Feb 20194:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20194:35 pmRNSPrice Monitoring Extension
12th Feb 20197:00 amRNSDebt Restructuring
1st Feb 20194:40 pmRNSSecond Price Monitoring Extn
1st Feb 20194:35 pmRNSPrice Monitoring Extension
22nd Jan 20197:00 amRNSChange of Registered Office
17th Jan 20197:00 amRNSMarket Update
20th Nov 20184:40 pmRNSSecond Price Monitoring Extn
20th Nov 20184:35 pmRNSPrice Monitoring Extension
16th Nov 20187:00 amRNSDirector Appointment
18th Oct 20184:40 pmRNSSecond Price Monitoring Extn
18th Oct 20184:35 pmRNSPrice Monitoring Extension
10th Oct 20187:00 amRNSQ3 2018 Update
20th Sep 20187:00 amRNSInterim Results
16th Jul 20187:00 amRNSH1 2018 Update
18th Jun 20187:00 amRNSMarket update
14th Jun 20187:00 amRNSGrant of Options
13th Jun 201811:30 amRNSResult of AGM
30th Apr 20187:00 amRNSFinal Results and Notice of AGM
18th Apr 20187:00 amRNSQ1 2018 Market Update
16th Apr 20181:30 pmRNSHolding(s) in Company
11th Apr 20186:20 pmRNSHolding(s) in Company
11th Apr 20186:20 pmRNSHolding(s) in Company
20th Mar 20183:05 pmRNSHolding(s) in Company
15th Mar 20181:24 pmRNSHolding(s) in Company
14th Feb 20187:00 amRNSProduction commences at IO#7
30th Jan 20183:00 pmRNSHolding(s) in Company
15th Jan 20187:00 amRNSMarket Update
14th Dec 20177:00 amRNSMarket Update
16th Nov 20177:00 amRNSIO#7 Progress and Market Update
20th Oct 20174:40 pmRNSSecond Price Monitoring Extn
20th Oct 20174:35 pmRNSPrice Monitoring Extension
10th Oct 20177:00 amRNSQ3 2017 Market Update
22nd Sep 20177:00 amRNSInterim Results
12th Sep 20177:00 amRNSConstruction of IO#7 to Expand Iodine Production
14th Jul 20177:00 amRNSCorporate and Production Update
14th Jun 201712:15 pmRNSResult of AGM
13th Jun 201712:07 pmRNSSecond Price Monitoring Extn
13th Jun 201712:02 pmRNSPrice Monitoring Extension
8th Jun 201712:07 pmRNSSecond Price Monitoring Extn
8th Jun 201712:02 pmRNSPrice Monitoring Extension
7th Jun 201712:07 pmRNSSecond Price Monitoring Extn
7th Jun 201712:02 pmRNSPrice Monitoring Extension
6th Jun 201712:07 pmRNSSecond Price Monitoring Extn
6th Jun 201712:02 pmRNSPrice Monitoring Extension
24th May 20174:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.